Cargando…

Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines

In recent years, adoptive cell therapy has gained a new perspective of application due to the development of technologies and the successful clinical use of CAR-T cells for the treatment of patients with malignant B-cell neoplasms. However, the efficacy of CAR-T therapy against solid tumor remains a...

Descripción completa

Detalles Bibliográficos
Autores principales: Valiullina, Aigul Kh., Zmievskaya, Ekaterina A., Ganeeva, Irina A., Zhuravleva, Margarita N., Garanina, Ekaterina E., Rizvanov, Albert A., Petukhov, Alexey V., Bulatov, Emil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953664/
https://www.ncbi.nlm.nih.gov/pubmed/36831162
http://dx.doi.org/10.3390/biomedicines11020626
_version_ 1784893934167654400
author Valiullina, Aigul Kh.
Zmievskaya, Ekaterina A.
Ganeeva, Irina A.
Zhuravleva, Margarita N.
Garanina, Ekaterina E.
Rizvanov, Albert A.
Petukhov, Alexey V.
Bulatov, Emil R.
author_facet Valiullina, Aigul Kh.
Zmievskaya, Ekaterina A.
Ganeeva, Irina A.
Zhuravleva, Margarita N.
Garanina, Ekaterina E.
Rizvanov, Albert A.
Petukhov, Alexey V.
Bulatov, Emil R.
author_sort Valiullina, Aigul Kh.
collection PubMed
description In recent years, adoptive cell therapy has gained a new perspective of application due to the development of technologies and the successful clinical use of CAR-T cells for the treatment of patients with malignant B-cell neoplasms. However, the efficacy of CAR-T therapy against solid tumor remains a major scientific and clinical challenge. In this work, we evaluated the cytotoxicity of 2nd generation CAR-T cells against modified solid tumors cell lines—lung adenocarcinoma cell line H522, prostate carcinoma PC-3M, breast carcinoma MDA-MB-231, and epidermoid carcinoma A431 cell lines transduced with lentiviruses encoding red fluorescent protein Katushka2S and the CD19 antigen. A correlation was demonstrated between an increase in the secretion of proinflammatory cytokines and a decrease in the confluence of tumor cells’ monolayer. The proposed approach can potentially be applied to preliminarily assess CAR-T cell efficacy for the treatment of solid tumors and estimate the risks of developing cytokine release syndrome.
format Online
Article
Text
id pubmed-9953664
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99536642023-02-25 Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines Valiullina, Aigul Kh. Zmievskaya, Ekaterina A. Ganeeva, Irina A. Zhuravleva, Margarita N. Garanina, Ekaterina E. Rizvanov, Albert A. Petukhov, Alexey V. Bulatov, Emil R. Biomedicines Article In recent years, adoptive cell therapy has gained a new perspective of application due to the development of technologies and the successful clinical use of CAR-T cells for the treatment of patients with malignant B-cell neoplasms. However, the efficacy of CAR-T therapy against solid tumor remains a major scientific and clinical challenge. In this work, we evaluated the cytotoxicity of 2nd generation CAR-T cells against modified solid tumors cell lines—lung adenocarcinoma cell line H522, prostate carcinoma PC-3M, breast carcinoma MDA-MB-231, and epidermoid carcinoma A431 cell lines transduced with lentiviruses encoding red fluorescent protein Katushka2S and the CD19 antigen. A correlation was demonstrated between an increase in the secretion of proinflammatory cytokines and a decrease in the confluence of tumor cells’ monolayer. The proposed approach can potentially be applied to preliminarily assess CAR-T cell efficacy for the treatment of solid tumors and estimate the risks of developing cytokine release syndrome. MDPI 2023-02-19 /pmc/articles/PMC9953664/ /pubmed/36831162 http://dx.doi.org/10.3390/biomedicines11020626 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Valiullina, Aigul Kh.
Zmievskaya, Ekaterina A.
Ganeeva, Irina A.
Zhuravleva, Margarita N.
Garanina, Ekaterina E.
Rizvanov, Albert A.
Petukhov, Alexey V.
Bulatov, Emil R.
Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
title Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
title_full Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
title_fullStr Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
title_full_unstemmed Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
title_short Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
title_sort evaluation of car-t cells’ cytotoxicity against modified solid tumor cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953664/
https://www.ncbi.nlm.nih.gov/pubmed/36831162
http://dx.doi.org/10.3390/biomedicines11020626
work_keys_str_mv AT valiullinaaigulkh evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT zmievskayaekaterinaa evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT ganeevairinaa evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT zhuravlevamargaritan evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT garaninaekaterinae evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT rizvanovalberta evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT petukhovalexeyv evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines
AT bulatovemilr evaluationofcartcellscytotoxicityagainstmodifiedsolidtumorcelllines